Plasma C-peptide and diagnosis of factitious hyperinsulinism. Study of an insulin-dependent diabetic patient with "spontaneous" hypoglycemia.
Factitious hyperinsulinism was suspected in a patient with an 11-year history of insulin-dependent, ketosis-prone diabetes mellitus who began to experience repetitive episodes of "spontaneous" hypoglycemia. Insulin mediation of the hypoglycemia was confirmed by documenting that urinary insulin and total extractable insulin in plasma increased during periods of hypoglycemia. Failure to detect significant amounts of human C-peptide by radioimmunoassay during periods of hypoglycemia or in response to stimulation with glucagon, leucine, or tolbutamide indicated that the insulin was not endogenous. The diagnosis of factitious hyperinsulinism was ultimately proved by the finding of radioactivity in the patient's urine after 131-I Hippuran was added to a vial of insulin found in the patient's room.
D003920:Diabetes Mellitus / Q000188:drug therapy*; D003937:Diagnosis, Differential; D005934:Glucagon; D005947:Glucose / Q000378:metabolism; D006801:Humans; D006946:Hyperinsulinism / Q000097:blood / Q000150:complications / Q000175:diagnosis*; D007003:Hypoglycemia / Q000175:diagnosis* / Q000209:etiology*; D007328:Insulin / Q000008:administration & dosage* / Q000378:metabolism; D007457:Iodine Radioisotopes; D007930:Leucine; D008297:Male; D008875:Middle Aged; D010455:Peptides / Q000097:blood*; D011863:Radioimmunoassay; D019966:Substance-Related Disorders / Q000150:complications*; D014044:Tolbutamide
D007328:Insulin; D007457:Iodine Radioisotopes; D010455:Peptides; D005934:Glucagon; D014044:Tolbutamide; D007930:Leucine; D005947:Glucose